

Nexalin Technology (NXL) stock surged 80% on massive volume following a 10-year South American distribution and manufacturing deal.
You can purchase shares of Nexalin Technology (NASDAQ:NXL) through any online brokerage.
Other companies in Nexalin Technology’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
Nexalin Technology has a consensus price target of $150.00.
The stock price for Nexalin Technology (NASDAQ: NXL) is $1.56 last updated November 5, 2026 at 6:51 AM EST.
There are no upcoming dividends for Nexalin Technology.
Nexalin Technology does not have any upcoming earnings scheduled.
There is no upcoming split for Nexalin Technology.
Nexalin Technology is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Nexalin Technology Inc designs and develops neurostimulation products and bioelectronic medical technology to treat anxiety and insomnia without drugs or psychotherapy. The Company has developed the Generation 1 (Gen 1) medical device, a cranial...